Presenilins and Alzheimer's disease: Biological functions and pathogenic mechanisms

Progress in Neurobiology

Volumn 60, Issue 4, 2000, Pages 363-384

  Czech, Christian ^a   Tremp, Günter ^a   Pradier, Laurent ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMYLOID PRECURSOR PROTEIN; BETA CATENIN; MEMBRANE PROTEIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; APOPTOSIS; ARABIDOPSIS; DEMENTIA; GENE MUTATION; HYDROPHOBICITY; MEMBRANE STRUCTURE; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ALZHEIMER DISEASE; ANIMALS; FEMALE; HUMANS; MEMBRANE PROTEINS; PREGNANCY; PRESENILIN-1; PRESENILIN-2;

EID: 0033990169     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00033-7     Document Type: Review

References (194)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. β -catenin is a target for the ubiquitin-proteasome pathway. Embo J. 16:1997;3797-3804.
2. Aldudo J., Bullido M., Arbizu T., Oliva R., Valdivieso F. Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease. Neurosci. Lett. 240:1998;174-176.
3. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatrie Psychisch-Gerichtlich. Med. 64:1907;146-148.
4. Alzheimer's Disease Collaborative Group, 1995. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer's Disease Collaborative Group. Nat. Genet. 11, 219-222.
5. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719.
6. Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid β -peptide deposition (letter). Nat. Genet. 17:1997;263-264.
7. Baumeister R., Leimer U., Zweckbronner I., Jakubek C., Grunberg J., Haass C. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes and Function. 1:1997;149-159.
8. Begley J.G., Duan W., Chan S., Duff K., Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72:1999;1030-1039.
9. Beher D., Elle C., Underwood J., Davis J.B., Ward R., Karran E., Masters C.L., Beyreuther K., Multhaup G. Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain. J. Neurochem. 72:1999;1564-1573.
10. Blanchard V., Czech C., Bonici B., Clavel N., Gohin M., Dalet K., Revah F., Pradier L., Imperato A., Moussaoui S. Immunohistochemical analysis of presenilin 2 expression in the mouse brain: distribution pattern and co-localization with presenilin 1 protein. Brain Res. 758:1997;209-217.
11. Boissiere F., Pradier L., Delaere P., Faucheux B., Revah F., Brice A., Agid Y., Hirsch E.C. Regional and cellular presenilin 2 (STM2) gene expression in the human brain. Neuroreport. 7:1996;2021-2025.
12. Bonilla E., Tanji K., Hirano M., Vu T.H., DiMauro S., Schon E.A. Mitochondrial involvement in Alzheimer's disease. Biochim. Biophys. Acta. 1410:1999;171-182.
13. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Ab1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
14. Boulianne G.L., Livne-Bar I., Humphreys J.M., Liang Y., Lin C., Rogaev E., St George-Hyslop P. Cloning and characterization of the Drosophila presenilin homologue. Neuroreport. 8:1997;1025-1029.
15. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.). 82:1991;239-259.
16. Brockhaus M., Grunberg J., Rohrig S., Loetscher H., Wittenburg N., Baumeister R., Jacobsen H., Haass C. Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport. 9:1998;1481-1486.
17. Bursztajn S., DeSouza R., McPhie D.L., Berman S.A., Shioi J., Robakis N.K., Neve R.L. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J. Neurosci. 18:1998;9790-9799.
18. Busciglio J., Gabuzda D.H., Matsudaira P., Yankner B.A. Generation of β -amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA. 90:1993;2092-2096.
19. Busciglio J., Hartmann H., Lorenzo A., Wong C., Baumann K., Sommer B., Staufenbiel M., Yankner B.A. Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J. Neurosci. 17:1997;5101-5107.
20. Buxbaum J.D., Choi E.K., Luo Y.X., Lilliehook C., Crowley A.C., Merriam D.E., Wasco W. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nature Med. 4:1998;1177-1181.
21. Calenda A., Mestre-Frances N., Czech C., Pradier L., Petter A., Bons N., Bellis M. Molecular cloning, sequencing, and brain expression of the presenilin 1 gene in Microcebus murinus. Biochem. Biophys. Res. Commun. 228:1996;430-439.
22. Calenda A., Mestre-Frances N., Czech C., Pradier L., Petter A., Perret M., Bons N., Bellis M. Cloning of the presenilin 2 cDNA and its distribution in brain of the primate, Microcebus murinus: coexpression with bAPP and tau proteins. Neurobiol. Dis. 5:1998;323-333.
23. Campion D., Brice A., Dumanchin C., Puel M., Baulac M., De La Sayette V., Hannequin D., Duyckaerts C., Michon A., Martin C., Moreau V., Penet C., Martinez M., Clerget-Darpoux F., Agid Y., Frebourg T. A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport. 7:1996;1582-1584.
24. Campion D., Flaman J.M., Brice A., Hannequin D., Dubois B., Martin C., Moreau V., Charbonnier F., Didierjean O., Tardieu S., et al. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4:1995;2373-2377.
25. Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., Beyreuther K., Selkoe D.J., Haass C. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150 kDa molecular mass complex. J. Biol. Chem. 273:1998;3205-3211.
26. Carter D.A., Desmarais E., Bellis M., Campion D., Clerget D.F., Brice A., Agid Y., Jaillard S.A., Mallet J. More missense in amyloid gene (letter). Nat. Genet. 2:1992;255-256.
27. Chartier-Harlin M., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β -amyloid precursor protein gene. Nature. 353:1991;844-846.
28. Citron M., Eckman C.B., Diehl T.S., Corcoran C., Ostaszewski B.L., Xia W., Levesque G., St George Hyslop P., Younkin S.G., Selkoe D.J. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid β -protein. Neurobiol. Dis. 5:1998;107-116.
29. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George-Hyslop P., Selkoe D. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β -protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
30. Conlon R.A., Reaume A.G., Rossant J. Notch1 is required for the coordinate segmentation of somites. Development. 121:1995;1533-1545.
31. Cook D., Forman M., Sung J., Leight S., Kolson D., Iwatsubo T., Lee V., Doms R. Alzheimer's A β (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3:1997;1021-1023.
32. Cook D.G., Sung J.C., Golde T.E., Felsenstein K.M., Wojczyk B.S., Tanzi R.E., Trojanowski J.Q., Lee V.M., Doms R.W. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA. 93:1996;9223-9228.
33. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C. Jr., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat. Genet. 7:1994;180-184.
34. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak V.M. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science. 261:1993;921-923.
35. Crook R., Verkkoniemi A., Perez T.J., Mehta N., Baker M., Houlden H., Farrer M., Hutton M., Lincoln S., Hardy J., Gwinn K., Somer M., Paetau A., Kalimo H., Ylikoski R., Poyhonen M., Kucera S., Haltia M. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat. Med. 4:1998;452-455.
36. Cruts M., Backhovens H., Wang S.Y., Gassen G.V., Theuns J., De Jonghe C.D., Wehnert A., De Voecht J., De Winter G., Cras P., et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4:1995;2363-2371.
37. Cruts M., Hendriks L., Van Broeckhoven C. The presenilin genes: a new gene family involved in Alzheimer's disease pathology. Hum. Mol. Genet. 5:1996;1449-1455.
38. Culvenor J.G., Maher F., Evin G., Malchiodi-Albedi F., Cappai R., Underwood J.R., Davis J.B., Karran E.H., Roberts G.W., Beyreuther K., Masters C.L. Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment. J. Neurosci. Res. 49:1997;719-731.
39. Czech C., Delaere P., Macq A.-F., Reibaud M., Dreisler S., Touchet N., Schomber B., Mazadier M., Mercken L., Theisen M., Pradier L., Octave J.-N., Beyreuther K., Tremp G.L. Proteolytical processing of mutated human amyloid protein precursor in transgenic mice. Mol. Brain Res. 47:1997;108-116.
40. Czech C., Lesort M., Tremp G., Terro F., Blanchard V., Schombert B., Carpentier N., Dreisler S., Bonici B., Takashima A., Moussaoui S., Hugon J., Pradier L. Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures. Neuroscience. 87:1998;325-336.
41. Davis J.A., Naruse S., Chen H., Eckman C., Younkin S., Price D.L., Borchelt D.R., Sisodia S.S., Wong P.C. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron. 20:1998;603-609.
42. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., Goate A., Kopan R. A presenilin-1-dependent γ -secretase-like protease mediates release of Notch intracellular domain. Nature. 398:1999;518-522.
43. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., George-Hyslop P.S., Van Leuven F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272:1997;3590-3598.
44. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
45. Deng G., Pike C.J., Cotman C.W. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett. 397:1996;50-54.
46. Deng G., Su J.H., Cotman C.W. Gene expression of Alzheimer-associated presenilin-2 in the frontal cortex of Alzheimer and aged control brain. FEBS Lett. 394:1996;17-20.
47. Dewji N.N., Singer S.J. Cell surface expression of the Alzheimer disease-related presenilin proteins. Proc. Natl. Acad. Sci. USA. 94:1997;9926-9931.
48. Doan A., Thinakaran G., Borchelt D.R., Slunt H.H., Ratovitsky T., Podlisny M., Selkoe D.J., Seeger M., Gandy S.E., Price D.L., Sisodia S.S. Protein topology of presenilin 1. Neuron. 17:1996;1023-1030.
49. Duff K., Eckman C., Zehr C.Y.X., Prada C.M., Perez-Tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid- β 42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
50. Dumanchin C., Brice A., Campion D., Hannequin D., Martin C., Moreau V., Agid Y., Martinez M., Clerget D.F., Frebourg T. De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group. J. Med. Genet. 35:1998;672-673.
51. Dumanchin, C., Czech, C., Campion, D., Poyot, T., Martin, C., Moreau, V., Charbonnier, F., Pradier, L., Frebourg, T., 1999. Presenilins interact with the Rab 11 protein, a member of a small GTPase superfamily involved in vesicle transport regulation, Hum. Mol. Genet. 8, 1263-1269.
52. Eckman C.B., Mehta N.D., Crook R., Perez-tur J., Prihar G., Pfeiffer E., Graff-Radford N., Hinder P., Yager D., Zenk B., Refolo L.M., Prada C.M., Younkin S.G., Hutton M., Hardy J. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A β 42(43). Hum. Mol. Genet. 6:1997;2087-2089.
53. Efthimiopoulos S., Floor E., Georgakopoulos A., Shioi J., Cui W., Yasothornsrikul S., Hook V.Y.H., Wisniewski T., Buee L., Robakis N.K. Enrichment of presenilin 1 peptides in neuronal large dense-core and somatodendritic clathrin-coated vesicles. J. Neurochem. 71:1998;2365-2372.
54. El Hachimi K., Cerenakova L., Brown P., Goldfarb L., Rubenstein R., Gadjusek D., Foncin J. Mixed features of Alzheimer's disease and Creutzfeld-Jacob disease in a family with presenilin mutation in chromosome 14. Amyloid. 3:1996;223-233.
55. Elder G.A., Tezapsidis N., Carter J., Shioi J., Bouras C., Li H.C., Johnston J.M., Efthimiopoulos S., Friedrich V.L.J., Robakis N.K. Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains. J. Neurosci. Res. 45:1996;308-320.
56. Forsell C., Froelich S., Axelman K., Vestling M., Cowburn R., Lilius L., Johnston J., Engvall B., Johansson K., Dahlkild A., Ingelson M., St G.-H.P., Lannfelt L. A novel pathogenic mutation (Leu262Phe) found in the presenilin 1 gene in early-onset Alzheimer's disease. Neurosci. Lett. 234:1997;3-6.
57. Furukawa K., Guo Q., Schellenberg G.D., Mattson M.P. Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52:1998;618-624.
58. Giannakopoulos P., Bouras C., Kovari E., Shioi J., Tezapsidis N., Hof P.R., Robakis N.K. Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am. J. Path. 150:1997;429-436.
59. Glenner, G.G., Wong, C.W., 1984. Alzheimer's disease: Initial report of the purification and characterisation of a novel cerebrovasclar amyloid protein. Biochem. Biophys. Res. Commun. 120, 885.
60. Goate A., Chartier H.M., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
61. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992;159-168.
62. Guo Q., Christakos S., Robinson N., Mattson M.P. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. USA. 95:1998;3227-3232.
63. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5:1999;101-106.
64. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β -peptide. Neuroreport. 8:1996;379-383.
65. Guo Q., Robinson N., Mattson M.P. Secreted β -amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis. J. Biol. Chem. 273:1998;12341-12351.
66. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β -peptide toxicity: central roles of superoxide production and caspase activation. J. Neurochem. 72:1999;1019-1029.
67. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β -peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
68. Haass C., Hung A.Y., Selkoe D.J., Teplow D.B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β -protein precursor. J. Biol. Chem. 269:1994;17741-17748.
69. Haass C., Schlossmacher M.G., Hung A.Y., Vigo P.C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J. Amyloid β -peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
70. Haass C., Selkoe D.J. Cellular processing of β -amyloid precursor protein and the genesis of amyloid β -peptide. Cell. 75:(0092-8674):1993;1039-1042.
71. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature. 397:1999;271-274.
72. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trens. Neurosci. 20:1997;154-159.
73. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Observation of metastable A β amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:1997;119-125.
74. Hartmann T., Bieger S., Bruhl B., Tienari P., Ida N., Allsop D., Roberts G., Masters C., Dotti C., Unsicker K., Beyreuther K. Distinct sites of intracellular production for Alzheimer's disease A β 40/42 amyloid peptides. Nat. Med. 3:1997;1016-1020.
75. Hendriks L., van D.C., Cras P., Cruts M., Van H.W., van Harskamp F., Warren A., McInnis M.G., Antonarakis S.E., Martin J.J. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β -amyloid precursor protein gene. Nat. Genet. 1:1992;218-221.
76. Hong C.S., Koo E.H. Isolation and characterization of Drosophila presenilin homolog. Neuroreport. 8:1997;665-668.
77. Hrabe de Angelis M., McIntyre II J., Gossler A. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature. 386:1997;717-721.
78. Hutton M., Busfield F., Wragg M., Crook R., Perez-Tu R.J., Clark R.F., Priha R.G., Talbot C., Phillips H., Wright K., Baker M., Lendon C., Duff K., Martinez A., Houlden H., Nichols A., Karran E., Roberts G., Roques P., Rossor M., Venter J.C., Adams M.D., Cline R.T., Phillips C.A., Goate A., et al. Complete analysis of the presenilin 1 gene in early-onset Alzheimer's disease. Neuroreport. 7:1996;801-805.
79. Ikeda M., Sharma V., Sumi S., Rogaeva E., Poorkaj P., Sherrington R., Nee L., Tsuda T., Oda N., Watanabe M., Aoki M., Shoji M., Abe K., Itoyama Y., Hirai S., Schellenberg G., Bird T., St George-Hyslop P. The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients. Ann. Neurol. 40:1996;912-917.
80. Imahori K., Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. (Tokyo). 121:1997;179-188.
81. Iwatsubo T. Ab42, presenilins, and Alzheimer's disease. Neurobiol. Aging. 19:1998;11-13.
82. Iwatsubo T., Mann D.M., Odaka A., Suzuki N., Ihara Y. Amyloid β protein (A β) deposition: A β 42(43) precedes A β 40 in Down syndrome. Ann. Neurol. 37:1995;294-299.
83. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A β 42(43) and A β 40 in senile plaques with end-specific A β monoclonals: evidence that an initially deposited species is A β 42(43). Neuron. 13:1994;45-53.
84. Janicki, S., Monteiro M.J., 1997. Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). Journal of Cell Biology 139, 485-495.
85. Jones C.T., Morris S., Yates C.M., Moffoot A., Sharpe C., Brock D.J., St Clair D. Mutation in codon 713 of the β amyloid precursor protein gene presenting with Schizophrenia. Nat. Genet. 1:1992;306-309.
86. Kamimura K., Tanahashi H., Yamanaka H., Takahashi K., Asada T., Tabira T. Familial Alzheimer's disease genes in Japanese. J. Neurol. Sci. 160:1998;76-81.
87. Kamino K., Orr H.T., Payami H., Wijsman E.M., Alonso M.E., Pulst S.M., Anderson L., O'dahl S., Nemens E., White J.A., et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am. J. Hum. Genet. 51:1992;998-1014.
88. Kamino K., Sato S., Sakaki Y., Yoshiiwa A., Nishiwaki Y., Takeda M., Tanabe H., Nishimura T., Li K., St George-Hyslop P.H., Miki T., Ogihara T. Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families. Neuroscience Letters. 208:1996;195-198.
89. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
90. Katzmann, R., 1976. The prevalence and malignanzy of AD: a major killer. Arch. Neurol. 33, 217-218.
91. Kim K.S., Wegiel J., Sapienza V., Chen J., Hong H., Wisniewski H.M. Immunoreactivity of presenilin-1 in human, rat and mouse brain. Brain Res. 757:1997;159-163.
92. Kim T.W., Pettingell W.H., Jung Y.K., Kovacs D.M., Tanzi R.E. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science. 277:1997;373-376.
93. Kovacs D.M., Fausett H.J., Page K.J., Kim T.W., Moir R.D., Merriam D.E., Hollister R.D., Hallmark O.G., Mancini R., Felsenstein K.M., Hyman B.T., Tanzi R.E., Wasco W. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:1996;224-229.
94. Kwok J., Taddei K., Hallupp M., Fisher C., Brooks W., Broe G., Hardy J., Fulham M., Nicholson G., Stell R., St G.H.P., Fraser P., Kakulas B., Clarnette R., Relkin N., Gandy S., Schofield P., Martins R. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport. 8:1997;1537-1542.
95. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
96. LaFerla F., Troncoso J., Strickland D., Kawas C., Jay G. Neuronal cell death in Alzheimer's disease correlates with ApoE uptake and intracellular A β stabilization. J. Clin. Invest. 100:1997;310-320.
97. Lah J.J., Heilman C.J., Nash N.R., Rees H.D., Yi H., Counts S.E., Levey A.I. Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17:1997;1971-1980.
98. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H.M. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropath. 89:1995;35-41.
99. Lee M.K., Slunt H.H., Martin L.J., Thinakaran G., Kim G., Gandy S.E., Seeger M., Koo E., Price D.L., Sisodia S.S. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16:1996;7513-7525.
100. Lehmann S., Chiesa R., Harris D.A. Evidence for a six-transmembrane domain structure of presenilin 1. J. Biol. Chem. 272:1997;12047-12051.
101. Leissring M.A., Paul B.A., Parker I., Cotman C.W., LaFerla F.M. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J. Neurochem. 72:1999;1061-1068.
102. Lemere C.A., Lopera F., Kosik K.S., Lendon C.L., Ossa J., Saido T.C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Arango J.C., Anthony D.C., Koo E.H., Goate A.M., Selkoe D.J., Arango J.C. The E280A presenilin 1 Alzheimer mutation produces increased A β 42 deposition and severe cerebellar pathology. Nat. Med. 2:1996;1146-1150.
103. Lendon C.L., Martinez A., Behrens I.M., Kosik K.S., Madrigal L., Norton J., Neuman R., Myers A., Busfield F., Wragg M., Arcos M., Arango Viana J.C., Ossa J., Ruiz A., Goate A.M., Lopera F. E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Hum. Mutat. 10:1997;186-195.
104. Levesque G., Yu G., Nishimura M., Zhang D.M., Levesque L., Yu H., Xu D., Liang Y., Rogaeva E., Ikeda M., Duthie M., Murgolo N., Wang L., VanderVere P., Bayne M.L., Strader C.D., Rommens J.M., Fraser P.E., St. George-Hyslop P. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and β -catenin. J. Neurochem. 72:1999;999-1008.
105. Levitan D., Doyle T.G., Brousseau D., Lee M.K., Thinakaran G., Slunt H.H., Sisodia S.S., Greenwald I. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 93:1996;14940-14944.
106. Levitan D., Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature. 377:1995;351-354.
107. Levy D. Membrane proteins which exhibit multiple topological orientations. Essays Biochem. 31:1996;49-60.
108. Levy E., Carman M.D., Fernandez M.I., Power M.D., Lieberburg I., van D.S., Bots G.T., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage. Dutch type Science. 248:1990;1124-1126.
109. Levy-Lahad E., Poorkaj P., Wang K., Fu Y.H., Oshima J., Mulligan J., Schellenberg G.D. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer's disease gene. Genomics. 34:1996;198-204.
110. Li J., Xu M., Zhou H., Ma J., Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 90:1997;917-927.
111. Li X., Greenwald I. Membrane topology of the C. elegans Sel-12 presenilin. Neuron. 17:1996;1015-1021.
112. Li X., Greenwald I. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proc. Natl. Acad. Sci. USA. 95:1998;7109-7114.
113. Lippa C.F., Nee L.E., Mori H., St George-Hyslop P. A β -42 deposition precedes other changes in PS-1 Alzheimer's disease (letter). Lancet. 352:1998;1117-1118.
114. Loetscher H., Deuschle U., Brockhaus M., Reinhardt D., Nelboeck P., Mous J., Grunberg J., Haass C., Jacobsen H. Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272:1997;20655-20659.
115. Masters C., Multhaup G., Simms G., Pottgieser J., Martins R., Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles contain the same protein as the amyloid of plaque cores and blood vessels. Embo J. 4:1985;2757-2763.
116. Masters C., Simms G., Weinmann N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
117. Mayeux R., Ottman R. Alzheimer's disease genetics: home runs and strikeouts (editorial). Ann. Neurol. 44:1998;716-719.
118. Moussaoui S., Czech C., Pradier L., Blanchard V., Bonici B., Gohin M., Imperato A., Revah F. Immunohistochemical analysis of presenilin-1 expression in the mouse brain. FEBS Lett. 383:1996;219-222.
119. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β -amyloid. Nat. Genet. 1:1992;345-347.
120. Murayama M., Tanaka S., Palacino J., Murayama O., Honda T., Sun X., Yasutake K., Nihonmatsu N., Wolozin B., Takashima A. Direct association of presenilin-1 with β -catenin. FEBS Lett. 433:1998;73-77.
121. Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
122. Naruse S., Thinakaran G., Luo J.J., Kusiak J.W., Tomita T., Iwatsubo T., Qian X., Ginty D.D., Price D.L., Borchelt D.R., Wong P.C., Sisodia S.S. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron. 21:1998;1213-1221.
123. National Institute on Aging, USA, 1998. Progress Report on Alzheimer's Disease.
124. Nishimura M., Yu G., Levesque G., Zhang D.M., Ruel L., Chen F., Milman P., Holmes E., Liang Y., Kawarai T., Jo E., Supala A., Rogaeva E., Xu D.M., Janus C., Levesque L., Bi Q., Duthie M., Rozmahel R., Mattila K., Lannfelt L., Westaway D., Mount H.T., Woodgett J., St George-Hyslop P., et al. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β -catenin, a component of the presenilin protein complex. Nat. Med. 5:1999;164-169.
125. Oyama F., Sawamura N., Kobayashi K., Morishima-Kawashima M., Kuramochi T., Ito M., Tomita T., Maruyama K., Saido T.C., Iwatsubo T., Capell A., Walter J., Grunberg J., Ueyama Y., Haass C., Ihara Y. Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid β -protein 42 in the brain. Journal of Neurochemistry. 71:1998;313-322.
126. Pahl H., Baeurle P. Endoplasmatic-reticulum induced signal transduction and gene expression. Trends in Cell Biology. 7:1997;50-55.
127. Peacock M., Murman D., Sima A., Warren J.J., Roses A., Fink J. Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease. Ann. Neurol. 35:1994;432-438.
128. Peacock M., Warren J., Roses A., Fink J. Novel polymorphism in the A4-region of the amyloid precursor protein gene in a patient without Alzheimer's disease. Neurology. 43:1992;1254-1256.
129. Peifer M., Berg S., Reynolds A.B. A repeating amino acid motif shared by proteins with diverse cellular roles (letter). Cell. 76:1994;789-791.
130. Perez-Tur L., Froehlich S., Prihar G., Crook R., Baker M., Duff K., Wragg M., Hardy J., Goate A., Lannfelt L., Hutton M. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin 1 gene. Neuroreport. 7:1996;297-301.
131. Podlisny M.B., Citron M., Amarante P., Sherrington R., Xia W., Zhang J., Diehl T., Levesque G., Fraser P., Haass C., Koo E.H., Seubert P., St George-Hyslop P., Teplow D.B., Selkoe D.J. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol. Dis. 3:1997;325-337.
132. Pradier L., Carpentier N., Delalonde L., Clavel N., Bock M.-D., Buée L., Mercken L., Tocqué B., Czech C. Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Neurobiol. Dis. 6:1999;43-55.
133. Pradier L., Czech C., Mercken L., Moussaoui S., Reibaud M., Delaère P., Tremp G. APP, APpoE and presenilin transgenics, toward a genetic model of Alzheimer's disease. Fisher A., Hanin I., Yoshida M. Progress in Alzheimer's and Parkinson's Disease. vol. 49:1998;Plenum Press, New York.
134. Qian S., Jiang P., Guan X.M., Singh G., Trumbauer M.E., Yu H., Chen H.Y., Van de Ploeg L.H., Zheng H. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates A β 1-42/43 expression. Neuron. 20:1998;611-617.
135. Quarteronet D., Pradier L., Czech C., Delalonde L., Burgevin M.C., Doble A., Petitet F. Localization of presenilin-1 mRNA in rat brain. Neuroreport. 7:1996;2587-2591.
136. Ramirez-Duenas M., Rogaeva E., Leal C., Lin C., Ramirez-Casillas G., Hernandez-Romo J., St George-Hyslop P., Cantu J. A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family with early onset Alzheimer disease. Ann. Genet. 41:1998;149-153.
137. Ray W.J., Yao M., Nowotny P., Mumm J., Zhang W., Wu J.Y., Kopan R., Goate A.M. Evidence for a physical interaction between presenilin and Notch. Proc. Natl. Acad. Sci. USA. 96:1999;3263-3268.
138. Resnik E. β -Catenin - one player, two games (news). Nat. Genet. 16:1997;9-11.
139. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
140. Rohan de Silva H.A., Patel A.J. Presenilins and early-onset familial Alzheimer's disease. Neuroreport. 8:1997;1-12.
141. Roperch J.P., Alvaro V., Prieur S., Tuynder M., Nemani M., Lethrosne F., Piouffre L., Gendron M.C., Israeli D., Dausset J., Oren M., Amson R., Telerman A. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat. Med. 4:1998;835-838.
142. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β -protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
143. Seeger M., Nordstedt C., Petanceska S., Kovacs D.M., Gouras G.K., Hahne S., Fraser P., Levesque L., Czernik A.J., George-Hyslop P.S., Sisodia S.S
144. Seubert P., Vigo P.C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., et al. Isolation and quantification of soluble Alzheimer's β -peptide from biological fluids. Nature. 359:1992;325-327.
145. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell. 89:1997;629-639.
146. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
147. Shinozaki K., Maruyama K., Kume H., Tomita T., Saido T.C., Iwatsubo T., Obata K. The presenilin 2 loop domain interacts with the mu-calpain C-terminal region. Int. J. Mol. Med. 1:1998;797-799.
148. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., Younkin S.G. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
149. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., Price D.L. Evidence that β -amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 248:1990;492-495.
150. Smine A., Xu X., Nishiyama K., Katada T., Gambetti P., Yadav S.P., Wu X., Shi Y.C., Yasuhara S., Homburger V., Okamoto T. Regulation of brain G-protein go by Alzheimer's disease gene presenilin-1. J. Biol. Chem. 273:1998;16281-16288.
151. Spacek J., Harris K.M. Three-dimensional organization of smooth endoplasmic reticulum in hippocampal CA1 dendrites and dendritic spines of the immature and mature rat. J. Neurosci. 17:1997;190-203.
152. St. George-Hyslop P.H. Role of genetics in tests of genotype, status, and disease progression in early-onset Alzheimer's disease. Neurobiol. Aging. 19:1998;133-137.
153. Steiner H., Romig H., Grim M.G., Philipp U., Pesold B., Citron M., Baumeister R., Haass C. The biological and pathological function of the presenilin-1 DeltaExon 9 mutation is independent of its defect to undergo proteolytic processing. J. Biol. Chem. 274:1999;7615-7618.
154. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak V.M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β -amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
155. Struhl G., Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 398:1999;522-525.
156. Su J.H., Anderson A.J., Cummings B.J., Cotman C.W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 5:1994;2529-2533.
157. Suzuki T., Nishiyama K., Murayama S., Yamamoto A., Sato S., Kanazawa I., Sakaki Y. Regional and cellular presenilin 1 gene expression in human and rat tissues. Biochem. Biophys. Res. Commun. 219:1996;708-713.
158. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., Nihonmatsu N., Mercken M., Yamaguchi H., Sugihara S., Wolozin B. Presenilin 1 associates with glycogen synthase kinase-3 β and its substrate tau. Proc. Natl. Acad. Sci. USA. 95:1998;9637-9641.
159. Takashima A., Sato M., Mercken M., Tanaka S., Kondo S., Honda T., Sato K., Murayama M., Noguchi K., Nakazato Y., Takahashi H. Localization of Alzheimer-associated presenilin 1 in transfected COS-7 cells. Biochem. Biophys. Res. Commun. 227:1996;423-426.
160. Tanimukai H., Imaizumi K., Kudo T., Katayama T., Tsuda M., Takagi T., Tohyama M., Takeda M. Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Mol. Brain Res. 54:1998;212-218.
161. Terasaki M., Slater N.T., Fein A., Schmidek A., Reese T.S. Continuous network of endoplasmic reticulum in cerebellar Purkinje neurons. Proc. Natl. Acad. Sci. USA. 91:1994;7510-7514.
162. Tesco G., Kim T.W., Diehlmann A., Beyreuther K., Tanzi R.E. Abrogation of the presenilin 1 β -catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation. J. Biol. Chem. 273:1998;33909-33914.
163. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.I., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
164. Thinakaran G., Harris C.L., Ratovitski T., Davenport F., Slunt H.H., Price D.L., Borchelt D.R., Sisodia S.S. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272:1997;28415-28422.
165. Thinakaran G., Regard J.B., Bouton C.M., Harris C.L., Price D.L., Borchelt D.R., Sisodia S.S. Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 4:1998;438-453.
166. Tomita T., Maruyama K., Saido T.C., Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grunberg J., Haass C., Iwatsubo T., Obata K. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid b protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA. 94:1997;2025-2030.
167. Tomita T., Tokuhiro S., Hashimoto T., Aiba K., Saido T.C., Maruyama K., Iwatsubo T. Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid β peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of A β 42. J. Biol. Chem. 273:1998;21153-21160.
168. Tsujimura A., Yasojima K., Hashimoto-Gotoh T. Cloning of Xenopus presenilin-alpha and -beta cDNAs and their differential expression in oogenesis and embryogenesis. Biochem. Biophys. Res. Commun. 231:1997;392-396.
169. Uchihara T., el Hachimi H.K., Duyckaerts C., Foncin J.F., Fraser P.E., Levesque L., St George-Hyslop P.H., Hauw J.J. Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains: double-labeling immunohistochemical study. Acta Neuropath. 92:1996;325-330.
170. Van Broeckhoven C., Backhovens H., Cruts M., Martin J.J., Crook R., Houlden H., Hardy J. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci. Lett. 169:1994;179-180.
171. Van de Craen M., de Jonghe C., van den Brande I., Declercq W., van Gassen G., van Criekinge W., Vanderhoeven I., Fiers W., van Broeckhoven C., Hendriks L., Vandenabeele P. Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases. FEBS Lett. 445:(PS1):1999;149-154.
172. Virchow, R. 1854. Virchows Arch. 6, 135-138.
173. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 271:1996;521-525.
174. Vito P., Wolozin B., Ganjei J.K., Iwasaki K., Lacana E.D., Adamio L. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 271:1996;31025-31028.
175. Walter J., Grunberg J., Capell A., Pesold B., Schindzielorz A., Citron M., Mendla K., George-Hyslop P.S., Multhaup G., Selkoe D.J., Haass C. Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C. Proc. Natl. Acad. Sci. USA. 94:1997;5349-5354.
176. Waragai M., Imafuku I., Takeuchi S., Kanazawa I., Oyama F., Udagawa Y., Kawabata M., Okazawa H. Presenilin 1 binds to amyloid precursor protein directly. Biochem. Biophys. Res. Commun. 239:1997;480-482.
177. Weidemann A., Paliga K., Dürrwang U., Czech C., Evin G., Masters C., Beyreuther K. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β -amyloid precursor protein. Nat. Med. 3:1997;328-332.
178. Wisniewski T., Dowjat W., Buxbaum J., Khorkova O., Efthimiopoulos S., Kulczycki J., Lojkowska W., Wegiel J., Wisniewski H., Frangione B. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport. 9:1998;217-221.
179. Wisniewski T., Ghiso J., Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 180:1991;1528.
180. Wolfe M., Xia W., Ostaszewski B., Diehl T., Taylor Kimberley X., Selkoe D. Two transmembrane aspartates in presenilin-1 required for endoproteolysis and γ -secretase activity. Nature. 398:1999;513-517.
181. Wolozin, B., Alexander, P., Palacino, J., 1998. Regulation of apoptosis by presenilin 1. Neurobiol. Aging 19 S25-27(1/2).
182. Wolozin B., Iwasaki K., Vito P., Ganjei J.K., Lacana E., Sunderland T., Zhao B., Kusiak J.W., Wasco W.D., Adamio L. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-1713.
183. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., Sisodia S.S. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 387:1997;288-292.
184. Xia W., Zhang J., Kholodenko D., Citron M., Podlisny M., Teplow D., Haass C., Seubert P., Koo E., Selkoe D. Enhanced production and oligomerization of the 42-residue amyloid β -protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272:1997;7977-7982.
185. Xia W., Zhang J., Ostaszewski B.L., Kimberly W.T., Seubert P., Koo E.H., Shen J., Selkoe D.J. Presenilin 1 regulates the processing of β -amyloid precursor protein C-terminal fragments and the generation of amyloid β -protein in endoplasmic reticulum and Golgi. Biochemistry. 37:1998;16465-16471.
186. Xia W., Zhang J., Perez R., Koo E., Selkoe D. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimers disease. Proc. Natl. Acad. Sci. USA. 94:1997;8208-8213.
187. Yamatsuji T., Okamoto T., Takeda S., Murayama Y., Tanaka N., Nishimoto I. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. Embo J. 15:1996;498-509.
188. Yasuda M., Maeda K., Hashimoto M., Yamashita H., Ikejiri Y., Bird T., Tanaka C., Schellenberg G. A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2. Arch. Neurol. 56:1999;65-69.
189. Ye Y., Lukinova N., Fortini M.E. Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants. Nature. 398:1999;525-529.
190. Yu G., Chen F., Levesque G., Nishimura M., Zhang D.M., Levesque L., Rogaeva E., Xu D., Liang Y., Duthie M., St George-Hyslop P.H., Fraser P.E. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β -catenin. J. Biol. Chem. 273:1998;16470-16475.
191. Zhang J., Duthie M., Ling V. Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule. J. Biol. Chem. 268:1993;15101-15110.
192. Zhang W., Han S.W., McKeel D.W., Goate A., Wu J.Y. Interaction of presenilins with the filamin family of actin-binding proteins. J. Neurosci. 18:1998;914-922.
193. Zhang Z.H., Hartmann H., Do V.M., Abramowski D., SturchlerPierrat C., Staufenbiel M., Sommer B., vandeWetering M., Clevers H., Saftig P., DeStrooper B., He X., Yankner B.A. Destabilization of β -catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 395:1998;698-702.
194. Zhou J., Liyanage U., Medina M., Ho C., Simmons A.D., Lovett M., Kosik K.S. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport. 8:1997;2085-2090.